These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34938173)

  • 21. Psychometric Properties of Alzheimer's Disease Assessment Scale-Cognitive Subscale for Mild Cognitive Impairment and Mild Alzheimer's Disease Patients in an Asian Context.
    Zainal NH; Silva E; Lim LL; Kandiah N
    Ann Acad Med Singap; 2016 Jul; 45(7):273-83. PubMed ID: 27523508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain structural alterations detected by an automatic quantified tool as an indicator for MCI diagnosing in type 2 diabetes mellitus patients: A magnetic resonance imaging study.
    Gu J; Cui S; Qi H; Li J; Wu W; Wang S; Ni J; Miao Z
    Heliyon; 2022 May; 8(5):e09390. PubMed ID: 35647347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disrupted Network Topology Contributed to Spatial Navigation Impairment in Patients With Mild Cognitive Impairment.
    Li W; Zhao H; Qing Z; Nedelska Z; Wu S; Lu J; Wu W; Yin Z; Hort J; Xu Y; Zhang B
    Front Aging Neurosci; 2021; 13():630677. PubMed ID: 34149391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes of brain structural network connection in Parkinson's disease patients with mild cognitive dysfunction: a study based on diffusion tensor imaging.
    Wang W; Mei M; Gao Y; Huang B; Qiu Y; Zhang Y; Wang L; Zhao J; Huang Z; Wang L; Nie K
    J Neurol; 2020 Apr; 267(4):933-943. PubMed ID: 31792673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Derivation of a new ADAS-cog composite using tree-based multivariate analysis: prediction of conversion from mild cognitive impairment to Alzheimer disease.
    Llano DA; Laforet G; Devanarayan V;
    Alzheimer Dis Assoc Disord; 2011; 25(1):73-84. PubMed ID: 20847637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired topographic organization in Parkinson's disease with mild cognitive impairment.
    Hou Y; Wei Q; Ou R; Yang J; Gong Q; Shang H
    J Neurol Sci; 2020 Jul; 414():116861. PubMed ID: 32387848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Volume changes in Alzheimer's disease and mild cognitive impairment: cognitive associations.
    Evans MC; Barnes J; Nielsen C; Kim LG; Clegg SL; Blair M; Leung KK; Douiri A; Boyes RG; Ourselin S; Fox NC;
    Eur Radiol; 2010 Mar; 20(3):674-82. PubMed ID: 19760240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.
    Gerretsen P; Chung JK; Shah P; Plitman E; Iwata Y; Caravaggio F; Nakajima S; Pollock BG; Graff-Guerrero A;
    J Clin Psychiatry; 2017; 78(9):e1187-e1196. PubMed ID: 29022655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of the Hungarian Test Your Memory (TYM-HUN), MMSE, and ADAS-Cog tests for patients with mild cognitive impairment (MCI) in a Hungarian population: a cross-sectional study.
    Garbóczy S; Magócs É; Szőllősi GJ; Harsányi S; Égerházi A; Kolozsvári LR
    BMC Psychiatry; 2020 Dec; 20(1):571. PubMed ID: 33256672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant voxel-based degree centrality in Parkinson's disease patients with mild cognitive impairment.
    Li MG; Bian XB; Zhang J; Wang ZF; Ma L
    Neurosci Lett; 2021 Jan; 741():135507. PubMed ID: 33217504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI.
    Landau SM; Harvey D; Madison CM; Koeppe RA; Reiman EM; Foster NL; Weiner MW; Jagust WJ;
    Neurobiol Aging; 2011 Jul; 32(7):1207-18. PubMed ID: 19660834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deficit of Cross-Frequency Integration in Mild Cognitive Impairment and Alzheimer's Disease: A Multilayer Network Approach.
    Wang X; Cui X; Ding C; Li D; Cheng C; Wang B; Xiang J
    J Magn Reson Imaging; 2021 May; 53(5):1387-1398. PubMed ID: 33244827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of Brain Structural Connectivity Networks and White Matter Integrity in Patients With Mild Cognitive Impairment.
    Bergamino M; Schiavi S; Daducci A; Walsh RR; Stokes AM
    Front Aging Neurosci; 2022; 14():793991. PubMed ID: 35173605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Validation of the Hungarian version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild cognitive impairment].
    Papp E; Pákáski M; Drótos G; Kálmán J
    Psychiatr Hung; 2012; 27(6):426-34. PubMed ID: 23429337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered topological organization of high-level visual networks in Alzheimer's disease and mild cognitive impairment patients.
    Deng Y; Shi L; Lei Y; Wang D;
    Neurosci Lett; 2016 Sep; 630():147-153. PubMed ID: 27461791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Joint Assessment of Quantitative 18F-Florbetapir and 18F-FDG Regional Uptake Using Baseline Data from the ADNI.
    Ben Bouallègue F; Mariano-Goulart D; Payoux P;
    J Alzheimers Dis; 2018; 62(1):399-408. PubMed ID: 29439345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain network alterations in individuals with and without mild cognitive impairment: parallel independent component analysis of AV1451 and AV45 positron emission tomography.
    Li Y; Yao Z; Yu Y; Zou Y; Fu Y; Hu B;
    BMC Psychiatry; 2019 Jun; 19(1):165. PubMed ID: 31159754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers.
    Ota K; Oishi N; Ito K; Fukuyama H; ;
    J Alzheimers Dis; 2016 Apr; 52(4):1385-401. PubMed ID: 27079727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.
    Nogueira J; Freitas S; Duro D; Almeida J; Santana I
    Clin Neuropsychol; 2018; 32(sup1):46-59. PubMed ID: 29566598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.